Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
31.72
-0.14 (-0.44%)
Aug 21, 2026, 9:29 AM EDT - Market open
Hims & Hers Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,578 | 2,348 | 1,477 | 872 | 526.92 | 271.88 | |
Revenue Growth | 28.04% | 59.00% | 69.33% | 65.49% | 93.81% | 82.77% |
Cost of Revenue | 785.57 | 614.26 | 303.38 | 157.05 | 118.19 | 67.38 |
Gross Profit | 1,793 | 1,733 | 1,173 | 714.95 | 408.72 | 204.49 |
Selling, General & Admin | 1,707 | 1,463 | 1,028 | 693.16 | 445.86 | 289.05 |
Research & Development | 183.38 | 149.3 | 78.82 | 48.23 | 29.24 | 22.38 |
Operating Expenses | 1,890 | 1,612 | 1,107 | 741.39 | 475.1 | 311.43 |
Operating Income | -97.37 | 121.16 | 65.88 | -26.44 | -66.38 | -106.94 |
Interest Expense | -9.33 | -3.9 | - | - | - | - |
Interest & Investment Income | 27.53 | 23.53 | 10.35 | 9.03 | 2.61 | 0.39 |
Other Non Operating Income (Expenses) | -26.78 | -5.75 | -0.54 | -1.15 | 0.38 | 3.86 |
EBT Excluding Unusual Items | -105.95 | 135.03 | 75.69 | -18.56 | -63.39 | -102.69 |
Gain (Loss) on Sale of Investments | -0.51 | 4.44 | - | - | - | - |
Asset Writedown | -1.15 | - | - | - | -1.13 | - |
Other Unusual Items | -15.54 | -15.54 | -3.98 | -3.02 | -1.19 | -8.11 |
Pretax Income | -163.61 | 123.92 | 71.71 | -21.57 | -65.71 | -110.8 |
Income Tax Expense | -21.58 | -4.44 | -54.33 | 1.98 | -0.03 | -3.14 |
Net Income | -142.03 | 128.37 | 126.04 | -23.55 | -65.68 | -107.66 |
Net Income to Common | -142.03 | 128.37 | 126.04 | -23.55 | -65.68 | -107.66 |
Net Income Growth | - | 1.85% | - | - | - | - |
Shares Outstanding (Basic) | 228 | 225 | 216 | 209 | 205 | 187 |
Shares Outstanding (Diluted) | 228 | 258 | 237 | 209 | 205 | 187 |
Shares Change | -7.33% | 9.05% | 13.12% | 2.36% | 9.50% | 428.32% |
EPS (Basic) | -0.62 | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 |
EPS (Diluted) | -0.62 | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 |
EPS Growth | - | -3.75% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 83.03 | 73.96 | 209.43 | 56.26 | -29.25 | -35.24 |
Free Cash Flow Per Share | 0.36 | 0.29 | 0.88 | 0.27 | -0.14 | -0.19 |
Gross Margin | 69.53% | 73.83% | 79.45% | 81.99% | 77.57% | 75.22% |
Operating Margin | -3.78% | 5.16% | 4.46% | -3.03% | -12.60% | -39.33% |
Profit Margin | -5.51% | 5.47% | 8.54% | -2.70% | -12.46% | -39.60% |
Free Cash Flow Margin | 3.22% | 3.15% | 14.18% | 6.45% | -5.55% | -12.96% |
EBITDA | -10.18 | 175.66 | 82.97 | -16.92 | -58.9 | -102.86 |
EBITDA Margin | -0.40% | 7.48% | 5.62% | -1.94% | -11.18% | -37.83% |
D&A For EBITDA | 87.19 | 54.5 | 17.09 | 9.52 | 7.47 | 4.08 |
EBIT | -97.37 | 121.16 | 65.88 | -26.44 | -66.38 | -106.94 |
EBIT Margin | -3.78% | 5.16% | 4.46% | -3.03% | -12.60% | -39.33% |
Advertising Expenses | - | 814.9 | 604.6 | 390.3 | 235.6 | 103.5 |